Mirador Capital Partners LP Raises Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Mirador Capital Partners LP grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 12.3% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 11,684 shares of the healthcare conglomerate’s stock after acquiring an additional 1,277 shares during the quarter. UnitedHealth Group comprises about 1.1% of Mirador Capital Partners LP’s holdings, making the stock its 21st largest position. Mirador Capital Partners LP’s holdings in UnitedHealth Group were worth $5,780,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently made changes to their positions in UNH. Vanguard Group Inc. lifted its position in shares of UnitedHealth Group by 0.3% during the fourth quarter. Vanguard Group Inc. now owns 83,860,515 shares of the healthcare conglomerate’s stock worth $44,150,045,000 after purchasing an additional 250,291 shares in the last quarter. Wellington Management Group LLP increased its holdings in UnitedHealth Group by 2.1% during the 3rd quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock worth $12,715,790,000 after purchasing an additional 527,526 shares during the last quarter. Capital Research Global Investors raised its holdings in UnitedHealth Group by 2.2% in the fourth quarter. Capital Research Global Investors now owns 15,122,203 shares of the healthcare conglomerate’s stock valued at $7,961,369,000 after acquiring an additional 324,733 shares in the last quarter. Capital International Investors grew its holdings in UnitedHealth Group by 4.8% during the 4th quarter. Capital International Investors now owns 11,860,985 shares of the healthcare conglomerate’s stock worth $6,244,158,000 after acquiring an additional 542,424 shares in the last quarter. Finally, Norges Bank acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $5,802,231,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

UNH stock traded down $3.68 on Monday, hitting $505.58. 107,757 shares of the company’s stock traded hands, compared to its average volume of 4,265,880. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.69. The stock has a market cap of $465.33 billion, a price-to-earnings ratio of 31.13, a P/E/G ratio of 1.48 and a beta of 0.60. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70. The stock has a fifty day moving average of $498.34 and a 200-day moving average of $501.63.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping the consensus estimate of $6.63 by $0.28. The company had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same period last year, the company posted $6.26 earnings per share. On average, analysts forecast that UnitedHealth Group Incorporated will post 27.55 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th were issued a dividend of $2.10 per share. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date was Monday, June 17th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.66%. UnitedHealth Group’s payout ratio is currently 51.34%.

Analyst Ratings Changes

A number of brokerages have weighed in on UNH. Deutsche Bank Aktiengesellschaft increased their target price on shares of UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a report on Friday, April 19th. Piper Sandler upped their target price on UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a report on Wednesday, April 17th. Cantor Fitzgerald restated an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, June 12th. StockNews.com lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Friday. Finally, Truist Financial reissued a “buy” rating and set a $600.00 target price on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Three equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $579.74.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.